亚急性脑梗死:18F-PSMA PET/CT 中放射性示踪剂摄取的罕见原因
本文报道一名78岁男性疑似前列腺癌复发患者,18F-PSMA PET/CT 显示脑内局灶性放射性示踪剂摄取,通常提示转移,但实为近期卒中背景下的假阳性。亚急性梗死及原发性和继发性脑肿瘤中已有 PSMA 摄取增高的报道,仔细询问病史并与既往影像对比对避免假阳性诊断至关重要。
要点
- 18F-PSMA PET/CT 脑内局灶性摄取并非一定为转移,亚急性脑梗死可致假阳性。
- 亚急性梗死及原发性和继发性脑肿瘤中已有 PSMA 摄取增高的报道。
- 仔细询问病史并与既往影像对比对避免此类假阳性诊断至关重要。
核心结论
- 亚急性脑梗死是18F-PSMA PET/CT 中放射性示踪剂摄取的罕见原因,可表现为假阳性。
研究设计与样本
- 本文为病例报告,对象为一名78岁疑似前列腺癌复发的男性患者。
主要发现
- 18F-PSMA PET/CT 显示该患者脑内局灶性放射性示踪剂摄取,通常提示转移,但实为近期卒中背景下的假阳性。
- 亚急性梗死及原发性和继发性脑肿瘤中已有 PSMA 摄取增高的报道。
临床怎么用
- 作者认为,仔细询问病史并与既往影像对比对避免此类患者的假阳性诊断至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) PET/CT has become an unparalleled modality in the diagnosis of primary and recurrent prostatic adenocarcinoma, often revealing sites of disease that were previously invisible on conventional imaging. In this 78-year-old man with suspected prostate cancer recurrence, PSMA PET/CT revealed focal radiotracer uptake in the brain, which would ordinarily raise suspicion for metastases, but was a false positive in the setting of a recent stroke. Increased PSMA uptake has been reported in subacute infarcts and primary and secondary brain tumors. Careful history and comparison with prior imaging are vital to avoid false-positive diagnosis in such patients.
引用
- Jain V, McIntosh L. Subacute Cerebral Infarct: An Unusual Cause of Radiotracer Uptake at 18 F-PSMA PET/CT. Clin Nucl Med. 2024. PMID: 38973086. doi:10.1097/RLU.0000000000005373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。